Study guide

16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea

DHA Pharmacist Licensing Assessment PHO5481

Track your progress as you read

Finished sections get a check mark.

1 Exam Overview & Licensing Pathway

1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan

2 Cardiovascular Pharmacology

2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents

3 Endocrine & Metabolic Pharmacology

3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents

4 Anti-Infective Pharmacology

4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars

5 CNS, Psychiatric & Pain Pharmacology

5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine

6 Respiratory, GI & Hematology Pharmacology

6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents

7 Pharmaceutical Care: Cardiometabolic Disease

7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management

8 Pharmaceutical Care: Respiratory, Rheumatology & Infection

8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship

9 Counseling, Monitoring & Special Populations

9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making

10 Pharmaceutical Calculations I

10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation

11 Pharmaceutical Calculations II

11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents

12 UAE Pharmacy Law & Regulation

12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity

13 Controlled Drugs, Ethics & Pharmacovigilance

13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal

14 Pharmacokinetics I: ADME

14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination

15 Pharmacokinetics II: Kinetics, Dosing & TDM

15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring

16 OTC Medicines & Self-Care

16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin

17 Medication Safety

17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition

18 Sterile & Nonsterile Compounding

18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding

19 Pharmaceutics, Biopharmaceutics & Toxicology

19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes

20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics

20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics

16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea

Key Takeaways Explain This Topic AI

Heartburn red flags requiring referral: dysphagia, odynophagia, weight loss, GI bleeding or haematemesis, anaemia, symptoms persisting beyond 2 weeks, and age >55 with new-onset dyspepsia.

Antacids (aluminium/magnesium hydroxide) suit occasional heartburn; H2-blockers (famotidine) and PPIs (omeprazole 20 mg) are for frequent symptoms — counsel short-term OTC use limits.

First-line constipation management is fibre, fluid, and an osmotic laxative (lactulose or macrogol); stimulants (senna, bisacodyl) are short-term rescue therapy.

Oral rehydration salts are the priority in acute diarrhoea; loperamide is appropriate for acute non-bloody, afebrile diarrhoea but must be AVOIDED if blood or high fever suggests invasive bacterial infection.

Diarrhoea red flags: blood/mucus in stool, severe dehydration, persistent >48 hours, and infants or frail elderly patients.

Last updated: August 2026

Heartburn and Dyspepsia

Heartburn is retrosternal burning from acid reflux. Lifestyle first: weight reduction, smaller meals, avoid late meals/lying down within 3 hours, limit caffeine, alcohol, spicy and fatty foods, stop smoking.

OTC options by frequency

Frequency Treatment Example

Occasional (intermittent) Antacid — rapid neutralisation Aluminium/magnesium hydroxide suspension 10–20 mL after meals and at bedtime

Frequent (≥2×/week) H2-blocker or PPI Famotidine 20 mg once or twice daily; omeprazole 20 mg once daily (take 30 min before breakfast)

Counsel PPI OTC use for a maximum of 14 days without medical advice; if symptoms recur after stopping, refer.

  • Heartburn red flags — REFER (do not treat OTC)
  • Dysphagia (difficulty swallowing) or odynophagia (painful swallowing)
  • Unintended weight loss
  • GI bleeding — haematemesis (vomiting blood) or melaena (black, tarry stools)
  • Anaemia on testing
  • Symptoms persisting beyond 2 weeks despite OTC therapy
  • Age >55 with new-onset dyspepsia (warrants endoscopy to exclude malignancy)
  • Severe epigastric pain, jaundice, previous gastric surgery, family history of GI cancer

Antacid counselling: magnesium-containing products may cause diarrhoea; aluminium-containing may cause constipation; separate antacids from other drugs by 2 hours (they can reduce absorption of antibiotics, iron, levothyroxine, PPIs).

Constipation

Constipation is fewer than 3 bowel movements per week, hard stools, or straining. First-line is non-pharmacological: fibre 25–30 g/day , adequate fluid (1.5–2 L), and exercise.

Laxative classes

Class Examples Use

Osmotic Lactulose 15–30 mL daily , macrogol (PEG 3350) sachets First-line; draws water into bowel; gentle, 1–2 day onset

Stimulant Senna 7.5–15 mg at night , bisacodyl 5–10 mg at night Short-term rescue; onset 8–12 h; avoid chronic use — bowel habituation, electrolyte disturbance, colonic atony

Bulk-forming Ispaghula (psyllium), methylcellulose Adjunct with fibre; must take with fluid to avoid obstruction

Stool softener Docusate sodium Mild; limited efficacy

Refer if: persistent constipation despite laxatives >2 weeks, blood in stool, severe abdominal pain, unexplained weight loss, alternating diarrhoea/constipation, or new onset in elderly (rule out obstruction or malignancy).

Acute Diarrhoea

Most acute diarrhoea is viral and self-limiting (1–5 days). The priority is fluid and electrolyte replacement .

Oral rehydration salts (ORS) — the cornerstone; take frequent small sips after each loose stool. Commercial sachets mixed to the stated volume (not diluted further).

Loperamide — antimotility; useful for acute, non-bloody, afebrile diarrhoea in adults when symptomatic control is needed (e.g. travel). Initial 4 mg, then 2 mg after each loose stool, max 16 mg/day .

When NOT to give loperamide

Avoid loperamide if any feature suggests invasive bacterial infection:

  • Blood or mucus in stools
  • High fever
  • Severe, prolonged illness

Loperamide can slow clearance of the organism and prolong toxin exposure, especially in Shigella, Salmonella, Campylobacter, E. coli O157 (risk of haemolytic uraemic syndrome).

  • Diarrhoea red flags — REFER
  • Blood/mucus in stool
  • Severe dehydration — sunken eyes, reduced skin turgor, dizziness, oliguria, drowsiness
  • Persistent >48 hours in adults (sooner in children/elderly)
  • Infants , frail elderly, immunocompromised, or pregnant patients
  • High fever, severe abdominal pain
  • Worked example — heartburn selection

A 42-year-old reports heartburn 3–4 times per week after large meals, no red flags, no weight loss, no dysphagia. This is frequent heartburn (≥2×/week). Lifestyle advice first (weight, late meals, alcohol, smoking). Because symptoms are frequent, a simple antacid is inadequate — recommend an H2-blocker (famotidine 20 mg once or twice daily) or a PPI (omeprazole 20 mg once daily, 30 min before breakfast) . Counsel a maximum of 14 days OTC use; if symptoms recur after stopping, or any red flag appears, refer. Separately, advise the patient that antacids taken alongside other medicines (iron, levothyroxine, antibiotics, PPIs) should be spaced by at least 2 hours to avoid reducing their absorption.

Worked example — constipation safety

A 70-year-old takes codeine for osteoarthritis and has not opened his bowels for 5 days. First-line is macrogol sachets (2–3 sachets daily in divided doses in water) plus fibre and fluid. If no response in 48 hours, add a stimulant ( senna 7.5 mg at night ). Stimulants are short-term rescue only; chronic codeine-related constipation needs medical review for ongoing opioid strategy. Refer urgently if abdominal pain, vomiting, distension or blood appears — possible obstruction in an elderly patient.

Worked example — traveller's diarrhoea

A 35-year-old returns from travel with watery diarrhoea for 1 day, no blood, no fever, well hydrated. Oral rehydration salts after each loose stool, plus loperamide 4 mg initially then 2 mg after each loose stool (max 16 mg/day) if he needs symptomatic control for travel. Counsel to stop loperamide and seek medical review if blood, high fever, or symptoms beyond 48 hours develop. Routine antibiotics are not an OTC pharmacy supply; refer if a suspected invasive bacterial cause or moderate-to-severe illness.

Key exam traps

PPI onset is not immediate — several days for full effect; counsel regular daily use, not PRN.

Loperamide is contraindicated in bloody/febrile invasive diarrhoea — it can worsen toxin-mediated disease.

Stimulant laxatives (senna, bisacodyl) for chronic use risk bowel habituation and electrolyte disturbance.

Antacids reduce absorption of many drugs — separate by 2 hours.

Age >55 with new-onset dyspepsia is a referral red flag , not a PPI trial.